Ann: Presentation to Investors, page-73

As I've already said before, there is no doubt that Biotron knows whether or not at least the COVID trial was successful or not from a clinical observations viewpoint and Prof Robert Murphy suggested as much in this presentation (go to 23:00)

"The pathway for this development is fast and furious and you're going to know very quickly about the effect in humans....."

So when I read today's presentation and note how very bullish our CEO is about both the HIV/COVID trials, it does give me a sense of optimism about the outcome